About
Technology
Issues
FAQ
Links
Official Page
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.